Matthias Scheffler

Papers authored by Matthias Scheffler

This paper is made freely available by the publisher.

2015 Katharina König, Martin Peifer

, Jana Fassunke, Michaela A. Ihle, Helen Künstlinger, Carina Heydt, Katrin Stamm, Frank Ueckeroth, Claudia Vollbrecht, Marc Bos, Masyar Gardizi, Matthias Scheffler

, Lucia Nogova, Frauke Leenders, Kerstin Albus and 20 other authors

Implementation of Amplicon Parallel Sequencing Leads to Improvement of Diagnosis and Therapy of Lung Cancer Patients

Download from doi.org

Ko Yd, Anne Schultheis, Matthias Scheffler

, Cristina Teixido

, Sebastian Michels, Daniela Morales-Espinosa, Santiago Viteri, Wolfgang Hartmann, Sabine Merkelbach-Bruse, Hans-Ulrich Schildhaus, Rieke Fischer, Schildhaus Hu, Jana Fassunke, Martin Sebastian, Monika Serke and 12 other authors

ROS1 rearrangements in lung adenocarcinoma: prognostic impact, therapeutic options and genetic variability

Download from dx.doi.org

This paper is available in a repository.

Matthias Scheffler

, Sabine Merkelbach-Bruse, Marc Bos, Jana Fassunke, Masyar Gardizi, Sebastian Michels, Laura Groneck, Anne M. Schultheis, Florian Malchers, Frauke Leenders, Carsten Kobe, Katharina König, Lukas C. Heukamp, Martin L. Sos, Roman K. Thomas and 2 other authors

Spatial Tumor Heterogeneity in Lung Cancer with Acquired Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Resistance: Targeting High-Level MET-Amplification and EGFR T790M Mutation Occurring at Different Sites in the Same Patient

Download from www.researchgate.net

Petra Hoffknecht, Amanda Tufman, Thomas Wehler, Theo Pelzer, Rainer Wiewrodt, Martin Schütz, Monika Serke, Jan Stöhlmacher-Williams, Angela Märten, Rudolf Maria Huber, Nicolas J. Dickgreber, Matthias Scheffler

Efficacy of the Irreversible ErbB Family Blocker Afatinib in Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI)–Pretreated Non–Small-Cell Lung Cancer Patients with Brain Metastases or Leptomeningeal Disease

Download from doi.org

2014 Matthias Scheffler

, Marc Bos, Masyar Gardizi, Katharina König, Sebastian Michels, Jana Fassunke, Carina Heydt, H. Kuenstlinger, Helen Künstlinger, Michaela Ihle, Frank Ueckeroth, Kerstin Albus, Monika Serke, K. Toepelt, Ulrich Gerigk and 17 other authors

PIK3CA mutations in non-small cell lung cancer (NSCLC): Genetic heterogeneity, prognostic impact and incidence of prior malignancies

Download from dx.doi.org

Ahmed Abbas Suleiman, Sebastian Frechen, Matthias Scheffler

, Thomas Zander, Deniz Kahraman, Carsten Kobe, Jürgen Wolf, Lucia Nogova, Uwe Fuhr

Modeling Tumor Dynamics and Overall Survival in Advanced Non–Small-Cell Lung Cancer Treated with Erlotinib

Download from doi.org

2013 Florian Malchers, Felix Dietlein, Jakob Schöttle, Xin Lu, Lucia Nogova, Kerstin Albus, Lynnette Fernandez-Cuesta, Johannes M. Heuckmann, Heuckmann Jm, Oliver Gautschi, Joachim Diebold, Dennis Plenker, Masyar Gardizi, Matthias Scheffler

, Marc Bos and 23 other authors

Cell-Autonomous and Non-Cell-Autonomous Mechanisms of Transformation by Amplified FGFR1 in Lung Cancer

Download from cancerdiscovery.aacrjournals.org

This paper was not found in any repository, but could be made available legally by the author.

M. Bos, M. Gardizi, H. U. Schildhaus, L. C. Heukamp, T. Geist, B. Kaminsky, T. Zander, L. Nogova, M. Scheffler

, M. Dietlein, C. Kobe, A. Holstein, D. Maintz, R. Büttner, J. Wolf

Complete metabolic response in a patient with repeatedly relapsed non-small cell lung cancer harboring ROS1 gene rearrangement after treatment with crizotinib

Upload

Matthias Scheffler

, Thomas Zander, Lucia Nogova, Carsten Kobe, Deniz Kahraman, Markus Dietlein, Irini Papachristou, Lukas Heukamp, Reinhard Büttner, Ron Boellaard, Adriaan A. Lammertsma, Silvia Querings, Erich Stoelben, Walburga Engel-Riedel, Bernd Neumaier and 1 other authors

Prognostic Impact of [18F]Fluorothymidine and [18F]Fluoro-D-Glucose Baseline Uptakes in Patients with Lung Cancer Treated First-Line with Erlotinib

Download from dx.doi.org

2012 Deniz Kahraman, Arne Holstein, Matthias Scheffler

, Thomas Zander, Lucia Nogova, Adriaan A. Lammertsma, Ronald Boellaard, Bernd Neumaier, Markus Dietlein, Jürgen Wolf, Carsten Kobe

Tumor Lesion Glycolysis and Tumor Lesion Proliferation for Response Prediction and Prognostic Differentiation in Patients With Advanced Non-Small Cell Lung Cancer Treated With Erlotinib

Download from www.researchgate.net

Matthias Scheffler

, Carsten Kobe, Thomas Zander, Lucia Nogova, Deniz Kahraman, Roman Thomas, Bernd Neumaier, Markus Dietlein, Jürgen Wolf

Monitoring reversible and irreversible EGFR inhibition with erlotinib and afatinib in a patient with EGFR-mutated non-small cell lung cancer (NSCLC) using sequential [18F]fluorothymidine (FLT-)PET

Download from www.researchgate.net

Carsten Kobe, Matthias Scheffler

, Arne Holstein, Thomas Zander, Lucia Nogova, Adriaan A. Lammertsma, Ronald Boellaard, Bernd Neumaier, Roland T. Ullrich, Markus Dietlein, Jürgen Wolf, Deniz Kahraman

Predictive value of early and late residual 18F-fluorodeoxyglucose and 18F-fluorothymidine uptake using different SUV measurements in patients with non-small-cell lung cancer treated with erlotinib

Download from www.researchgate.net

2011 Deniz Kahraman, Matthias Scheffler

, Thomas Zander, Lucia Nogova, Adriaan A. Lammertsma, Ronald Boellaard, Bernd Neumaier, Roland T. Ullrich, Arne Holstein, Markus Dietlein, Jürgen Wolf, Carsten Kobe

Quantitative Analysis of Response to Treatment with Erlotinib in Advanced Non–Small Cell Lung Cancer Using ¹⁸F-FDG and 3′-Deoxy-3′-¹⁸F-Fluorothymidine PET

Upload

Thomas Zander, Matthias Scheffler

, Lucia Nogova, Jürgen Wolf

Reply to M. Quintela-Fandino et al

Download from www.researchgate.net

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

P. Di Gion, F. Kanefendt, A. Lindauer, M. Scheffler

, O. Doroshyenko, U. Fuhr, J. Wolf, U. Jaehde

Clinical pharmacokinetics of tyrosine kinase inhibitors: focus on pyrimidines, pyridines and pyrroles.

Upload

M. Scheffler

, P. Di Gion, O. Doroshyenko, J. Wolf, U. Fuhr

Clinical pharmacokinetics of tyrosine kinase inhibitors: focus on 4-anilinoquinazolines.

Upload

Silvia Querings, Janine Altmüller

, Sascha Ansén, Thomas Zander, Danila Seidel, Franziska Gabler, Martin Peifer

, Eva Markert, Kathryn Stemshorn, Bernd Timmermann, Beate Saal, Stefan Klose, Karen Ernestus, Matthias Scheffler

, Walburga Engel-Riedel and 5 other authors

Benchmarking of Mutation Diagnostics in Clinical Lung Cancer Specimens

Download from doi.org

Thomas Zander, Matthias Scheffler

, Lucia Nogova, Carsten Kobe, Walburga Engel-Riedel, Martin Hellmich, Irini Papachristou, Karin Toepelt, Andreas Draube, Lukas Heukamp, Reinhard Buettner, Yon D. Ko, Roland T. Ullrich, Egbert Smit, Ronald Boellaard and 11 other authors

Early Prediction of Nonprogression in Advanced Non–Small-Cell Lung Cancer Treated With Erlotinib By Using [¹⁸F]Fluorodeoxyglucose and [¹⁸F]Fluorothymidine Positron Emission Tomography

Download from doi.org

2010 Sascha Ansén, Christopher Bangard, Silvia Querings, Franziska Gabler, Matthias Scheffler

, Daniela Seidel, Beate Saal, Thomas Zander, Lucia Nogová, Karin Töpelt, Eva Markert, Erich Stoelben, Karen Ernestus, Roman K. Thomas, Jürgen Wolf

Osteoblastic Response in Patients with Non-small Cell Lung Cancer with Activating EGFR Mutations and Bone Metastases during Treatment with EGFR Kinase Inhibitors

Download from doi.org

2009 M. Scheffler

, J. Wolf

Aktuelle Entwicklungen in der Bildgebung beim nichtkleinzelligen Bronchialkarzinom

Upload

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

Papers authored by Matthias Scheffler